{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:23:33Z","timestamp":1761593013125,"version":"build-2065373602"},"reference-count":122,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ncl.2025.05.006","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T19:49:14Z","timestamp":1756756154000},"page":"673-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic Neuropathy Part 1"],"prefix":"10.1016","volume":"43","author":[{"given":"Long","family":"Davalos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamatha","family":"Pasnoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ncl.2013.02.004","article-title":"Diabetic neuropathy part 1: overview and symmetric phenotypes","volume":"31","author":"Pasnoor","year":"2013","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/oxfordjournals.aje.a115547","article-title":"Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis valley diabetes study","volume":"131","author":"Franklin","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199507133330203","article-title":"Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"Partanen","year":"1995","journal-title":"N Engl J Med"},{"issue":"10397","key":"10.1016\/j.ncl.2025.05.006_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ncl.2025.05.006_bib7","article-title":"Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study","volume":"362","author":"Xu","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diacare.8.2.125","article-title":"The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population","volume":"8","author":"Boulton","year":"1985","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8227(98)00100-4","article-title":"Diabetic neuropathy in Mauritius: prevalence and risk factors","volume":"42","author":"Shaw","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1464-5491.2008.02397.x","article-title":"Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55)","volume":"25","author":"Pradeepa","year":"2008","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib12","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/dc17-2062","article-title":"Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 Years: ADDITION-Denmark","volume":"41","author":"Andersen","year":"2018","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib13","first-page":"97","article-title":"[Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author\u2019s transl)]","volume":"3","author":"Pirart","year":"1977","journal-title":"Diabete Metab"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.006_bib14","first-page":"173","article-title":"[Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (2nd part) (author\u2019s transl)]","volume":"3","author":"Pirart","year":"1977","journal-title":"Diabete Metab"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib15","first-page":"245","article-title":"[Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author\u2019s transl)]","volume":"3","author":"Pirart","year":"1977","journal-title":"Diabete Metab"},{"issue":"18","key":"10.1016\/j.ncl.2025.05.006_bib16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJM199505043321807","article-title":"Prevention and treatment of the complications of diabetes mellitus","volume":"332","author":"Clark","year":"1995","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ncl.2025.05.006_bib17","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.neuron.2023.05.003","article-title":"New perspectives in diabetic neuropathy","volume":"111","author":"Eid","year":"2023","journal-title":"Neuron"},{"issue":"14","key":"10.1016\/j.ncl.2025.05.006_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the diabetes control and complications trial (DCCT) on peripheral neuropathy in type 1 diabetes during the epidemiology of diabetes interventions and complications (EDIC) study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ncl.2025.05.006_bib20","first-page":"CD007543","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","volume":"6","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"9739","key":"10.1016\/j.ncl.2025.05.006_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/138945008783431781","article-title":"Aldose reductase, still a compelling target for diabetic neuropathy","volume":"9","author":"Oates","year":"2008","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ame2.12001","article-title":"Redox imbalance stress in diabetes mellitus: role of the polyol pathway","volume":"1","author":"Yan","year":"2018","journal-title":"Anim Models Exp Med"},{"issue":"6865","key":"10.1016\/j.ncl.2025.05.006_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.006_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12272-019-01130-3","article-title":"Recent advances in the pathogenesis of microvascular complications in diabetes","volume":"42","author":"Park","year":"2019","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biom5010194","article-title":"Advanced glycation end products and oxidative stress in type 2 diabetes mellitus","volume":"5","author":"Nowotny","year":"2015","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.ncl.2025.05.006_bib28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/138161208784139774","article-title":"Role of advanced glycation end products in diabetic neuropathy","volume":"14","author":"Sugimoto","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2006-0073","article-title":"Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress","volume":"148","author":"Vincent","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1096\/fj.201700206R","article-title":"Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons","volume":"32","author":"Rumora","year":"2018","journal-title":"Faseb J"},{"key":"10.1016\/j.ncl.2025.05.006_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2010.11.013","article-title":"Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity","volume":"1370","author":"Padilla","year":"2011","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.006_bib32","first-page":"137","article-title":"Essential role of NOXA1 in generation of reactive oxygen species induced by oxidized low-density lipoprotein in human vascular endothelial cells","volume":"15","author":"Honjo","year":"2008","journal-title":"Endothel J Endothel Cell Res"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/dmrr.1088","article-title":"Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction","volume":"26","author":"Davidson","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jns.12111","article-title":"Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl\/6J mice","volume":"20","author":"Yorek","year":"2015","journal-title":"J Peripher Nerv Syst JPNS"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ncl.2025.05.006_bib36","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2337\/db08-1771","article-title":"Elevated triglycerides correlate with progression of diabetic neuropathy","volume":"58","author":"Wiggin","year":"2009","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jdiacomp.2013.04.003","article-title":"Obesity and hyperlipidemia are risk factors for early diabetic neuropathy","volume":"27","author":"Smith","year":"2013","journal-title":"J Diabetes Complications"},{"issue":"10","key":"10.1016\/j.ncl.2025.05.006_bib38","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2337\/diabetes.52.10.2615","article-title":"Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man","volume":"52","author":"Thrainsdottir","year":"2003","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ncl.2025.05.006_bib39","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/BF00400804","article-title":"Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography","volume":"36","author":"Tesfaye","year":"1993","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","article-title":"Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications","volume":"11","author":"Tabit","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"1\u20133","key":"10.1016\/j.ncl.2025.05.006_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2013.07.017","article-title":"Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms","volume":"719","author":"Van Dam","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"6554","key":"10.1016\/j.ncl.2025.05.006_bib42","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/bmj.293.6554.1053","article-title":"Sural nerve oxygen tension in diabetes","volume":"293","author":"Newrick","year":"1986","journal-title":"Br Med J Clin Res Ed"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1212\/WNL.39.1.111","article-title":"Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture","volume":"39","author":"Dyck","year":"1989","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.006_bib44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/brain\/93.3.555","article-title":"Oculomotor palsy in diabetes mellitus: a clinico-pathological study","volume":"93","author":"Asbury","year":"1970","journal-title":"Brain J Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2025.05.006_bib45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1212\/WNL.20.8.835","article-title":"Pathology of oculomotor nerve palsy in diabetics","volume":"20","author":"Weber","year":"1970","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneurpsyc.1957.02330340013001","article-title":"Diabetic ophthalmoplegia; report of case, with postmortem study and comments on vascular supply of human oculomotor nerve","volume":"77","author":"Dreyfus","year":"1957","journal-title":"AMA Arch Neurol Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM196807042790104","article-title":"Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus","volume":"279","author":"Raff","year":"1968","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ncl.2025.05.006_bib48","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archneur.1991.00530230038018","article-title":"The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later","volume":"48","author":"Barohn","year":"1991","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2025.05.006_bib49","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4065\/72.12.1123","article-title":"Subacute diabetic proximal neuropathy","volume":"72","author":"Pascoe","year":"1997","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.ncl.2025.05.006_bib50","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1212\/WNL.53.9.2113","article-title":"Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy","volume":"53","author":"Dyck","year":"1999","journal-title":"Neurology"},{"issue":"7121","key":"10.1016\/j.ncl.2025.05.006_bib51","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ncl.2025.05.006_bib52","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Investig"},{"issue":"6917","key":"10.1016\/j.ncl.2025.05.006_bib53","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.006_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","article-title":"Inflammation as a therapeutic target for diabetic neuropathies","volume":"16","author":"Pop-Busui","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/er.2018-00107","article-title":"Emerging biomarkers, tools, and treatments for diabetic polyneuropathy","volume":"40","author":"B\u00f6nhof","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib56","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1530\/EJE-15-1010","article-title":"Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes","volume":"174","author":"Schamarek","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc16-2259","article-title":"Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4\/FF4 study","volume":"40","author":"Herder","year":"2017","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ncl.2025.05.006_bib58","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2008-2385","article-title":"Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy","volume":"94","author":"Doupis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ncl.2025.05.006_bib59","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/(SICI)1097-4598(199606)19:6<722::AID-MUS6>3.0.CO;2-C","article-title":"Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies","volume":"19","author":"Younger","year":"1996","journal-title":"Muscle Nerve"},{"issue":"Pt 11","key":"10.1016\/j.ncl.2025.05.006_bib60","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/brain\/awr228","article-title":"The identification of gene expression profiles associated with progression of human diabetic neuropathy","volume":"134","author":"Hur","year":"2011","journal-title":"Brain J Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36098-5","article-title":"Conserved transcriptional signatures in human and murine diabetic peripheral neuropathy","volume":"8","author":"McGregor","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.10080","article-title":"Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment","volume":"25","author":"Dyck","year":"2002","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.ncl.2025.05.006_bib63","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneur.1995.00540350039015","article-title":"Successful treatment of neuropathies in patients with diabetes mellitus","volume":"52","author":"Krendel","year":"1995","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00690213","article-title":"Hypertrophic changes in diabetic neuropathy","volume":"11","author":"Ballin","year":"1968","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib65","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0022-510X(73)90133-0","article-title":"[Peripheral neuropathies caused by diabetes mellitus. Ultrastructural study of 12 biopsied cases]","volume":"18","author":"Vital","year":"1973","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00685323","article-title":"[Ultrastructural study of pheripheral nerve in 16 diabetics without neuropathy. Comparisons with 16 diabetic neuropathies and 16 non-diabetic neuropathies (author\u2019s transl)]","volume":"30","author":"Vital","year":"1974","journal-title":"Acta Neuropathol (Berl)"},{"issue":"Pt 4","key":"10.1016\/j.ncl.2025.05.006_bib67","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/brain\/106.4.791","article-title":"Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy","volume":"106","author":"Said","year":"1983","journal-title":"Brain J Neurol"},{"issue":"19","key":"10.1016\/j.ncl.2025.05.006_bib68","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJM199205073261905","article-title":"Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study","volume":"326","author":"Said","year":"1992","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410190503","article-title":"Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy","volume":"19","author":"Dyck","year":"1986","journal-title":"Ann Neurol"},{"issue":"Pt 4","key":"10.1016\/j.ncl.2025.05.006_bib70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/108.4.861","article-title":"Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy","volume":"108","author":"Dyck","year":"1985","journal-title":"Brain J Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2025.05.006_bib71","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/mus.880160711","article-title":"Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function","volume":"16","author":"Claus","year":"1993","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.46.1.85","article-title":"Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial","volume":"46","author":"Albers","year":"1996","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2025.05.006_bib73","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/jnnp.40.11.1072","article-title":"Nerve biopsy and conduction studies in diabetic neuropathy","volume":"40","author":"Behse","year":"1977","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.ncl.2025.05.006_bib74","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00005072-199612000-00001","article-title":"Pathologic alterations in the diabetic neuropathies of humans: a review","volume":"55","author":"Dyck","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib75","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc subcommittee of the American Academy of Neurology AIDS task force","volume":"41","year":"1991","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2025.05.006_bib76","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/jnnp-2020-324399","article-title":"Chronic inflammatory demyelinating polyneuropathy and diabetes","volume":"91","author":"Kuwabara","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1212\/WNL.0b013e3181aaea47","article-title":"Incidence and prevalence of CIDP and the association of diabetes mellitus","volume":"73","author":"Laughlin","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2025.05.006_bib78","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1468-1331.2009.02598.x","article-title":"Comorbidity between CIDP and diabetes mellitus: only a matter of chance?","volume":"16","author":"Chi\u00f2","year":"2009","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2025.05.006_bib79","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/jnnp-2020-323615","article-title":"Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy","volume":"91","author":"Doneddu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.ncl.2025.05.006_bib80","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/jnnp-2020-322971","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal","volume":"91","author":"Rajabally","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.ncl.2025.05.006_bib81","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jdiacomp.2016.05.007","article-title":"The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy","volume":"30","author":"Bril","year":"2016","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-510X(99)00317-2","article-title":"The spectrum of chronic inflammatory demyelinating polyneuropathy","volume":"173","author":"Rotta","year":"2000","journal-title":"J Neurol Sci"},{"issue":"11","key":"10.1016\/j.ncl.2025.05.006_bib83","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2025.05.006_bib84","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib85","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/j.pain.0000000000000491","article-title":"The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy","volume":"157","author":"Themistocleous","year":"2016","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.ncl.2025.05.006_bib86","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ncl.2025.05.006_bib87","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1111\/ene.14469","article-title":"Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes","volume":"27","author":"Gylfadottir","year":"2020","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.006_bib88","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archneur.1981.00510010072013","article-title":"Diabetic truncal polyneuropathy","volume":"38","author":"Waxman","year":"1981","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2025.05.006_bib90","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.ncl.2025.05.006_bib91","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","article-title":"Validation of the Toronto clinical scoring system for diabetic polyneuropathy","volume":"25","author":"Bril","year":"2002","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.006_bib92","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-5491.2009.02667.x","article-title":"Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy","volume":"26","author":"Bril","year":"2009","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.006_bib93","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1529-8027.2008.00180.x","article-title":"The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy","volume":"13","author":"Singleton","year":"2008","journal-title":"J Peripher Nerv Syst JPNS"},{"issue":"7","key":"10.1016\/j.ncl.2025.05.006_bib94","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2337\/dc09-1835","article-title":"Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study","volume":"33","author":"Perkins","year":"2010","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.ncl.2025.05.006_bib95","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.2010.428","article-title":"Does this patient with diabetes have large-fiber peripheral neuropathy?","volume":"303","author":"Kanji","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.006_bib96","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.410380323","article-title":"Diabetic polyneuropathy in controlled clinical trials: consensus report of the peripheral nerve society","volume":"38","year":"1995","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2025.05.006_bib97","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1212\/WNL.42.6.1164","article-title":"The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity","volume":"42","author":"Dyck","year":"1992","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.ncl.2025.05.006_bib98","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/sim.7009","article-title":"Discovering early diabetic neuropathy from epidermal nerve fiber patterns","volume":"35","author":"Andersson","year":"2016","journal-title":"Stat Med"},{"issue":"Pt 7","key":"10.1016\/j.ncl.2025.05.006_bib99","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/brain\/awn093","article-title":"The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology","volume":"131","author":"Devigili","year":"2008","journal-title":"Brain J Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-019-0097-9","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primer"},{"issue":"6","key":"10.1016\/j.ncl.2025.05.006_bib101","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006559","article-title":"Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes","volume":"5","author":"Ziegler","year":"2015","journal-title":"BMJ Open"},{"issue":"6556","key":"10.1016\/j.ncl.2025.05.006_bib102","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.293.6556.1195","article-title":"Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study","volume":"293","author":"Dahl-J\u00f8rgensen","year":"1986","journal-title":"Br Med J Clin Res Ed"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2337\/dc18-1560","article-title":"Improvement in neuropathy outcomes with Normalizing HbA1c in patients with type 2 diabetes","volume":"42","author":"Ishibashi","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ncl.2025.05.006_bib105","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-017-4253-z","article-title":"Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study","volume":"60","year":"2017","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.ncl.2025.05.006_bib106","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/oby.23246","article-title":"Dietary weight loss in people with severe obesity stabilizes neuropathy and improves symptomatology","volume":"29","author":"Callaghan","year":"2021","journal-title":"Obes Silver Spring Md"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib107","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jdiacomp.2012.05.007","article-title":"The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy","volume":"26","author":"Kluding","year":"2012","journal-title":"J Diabetes Complications"},{"issue":"6","key":"10.1016\/j.ncl.2025.05.006_bib108","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00262218","article-title":"Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy","volume":"26","author":"Lewin","year":"1984","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.006_bib109","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/1056-8727(92)90023-E","article-title":"Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom\/Scandinavian Ponalrestat Trial","volume":"6","author":"Sundkvist","year":"1992","journal-title":"J Diabetes Complications"},{"issue":"Suppl 2","key":"10.1016\/j.ncl.2025.05.006_bib110","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.2337\/diab.46.2.S82","article-title":"Aldose reductase inhibitors: the end of an era or the need for different trial designs?","volume":"46","author":"Pfeifer","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.ncl.2025.05.006_bib111","first-page":"79","article-title":"Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription","volume":"38","author":"Packer","year":"1997","journal-title":"Adv Pharmacol San Diego Calif"},{"issue":"8","key":"10.1016\/j.ncl.2025.05.006_bib112","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2337\/diacare.18.8.1160","article-title":"Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy","volume":"18","author":"Nagamatsu","year":"1995","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ncl.2025.05.006_bib113","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/BF00400603","article-title":"Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)","volume":"38","author":"Ziegler","year":"1995","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.ncl.2025.05.006_bib114","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc06-1216","article-title":"Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial","volume":"29","author":"Ziegler","year":"2006","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ncl.2025.05.006_bib115","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/dc11-0503","article-title":"Efficacy and safety of antioxidant treatment with \u03b1-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial","volume":"34","author":"Ziegler","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib116","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.28.1.89","article-title":"Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials","volume":"28","author":"Sima","year":"2005","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib117","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/db23-0377","article-title":"Acetyllevocarnitine hydrochloride for the treatment of diabetic peripheral neuropathy: a phase 3 randomized clinical trial in China","volume":"73","author":"Guo","year":"2024","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.006_bib118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.0000000000013038","article-title":"Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN guideline subcommittee","volume":"98","author":"Price","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.006_bib119","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/B978-0-444-53491-0.00022-5","article-title":"Diabetic autonomic neuropathy","volume":"117","author":"Vinik","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2025.05.006_bib120","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.clinthera.2022.09.002","article-title":"Cardiac autonomic neuropathy in type 1 and 2 diabetes: epidemiology, pathophysiology, and management","volume":"44","author":"Williams","year":"2022","journal-title":"Clin Ther"},{"key":"10.1016\/j.ncl.2025.05.006_bib121","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/B978-0-444-52902-2.00007-2","article-title":"Testing the autonomic nervous system","volume":"115","author":"Freeman","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.006_bib122","first-page":"680","article-title":"Diabetic neuropathic cachexia: a clinical case and review of literature","volume":"12","author":"Bellelli","year":"2022","journal-title":"Life Basel Switz"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2025.05.006_bib123","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/awu307","article-title":"Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes","volume":"138","author":"Gibbons","year":"2015","journal-title":"Brain J Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2025.05.006_bib124","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11892-017-0880-5","article-title":"Microvascular complications associated with rapid improvements in glycemic control in diabetes","volume":"17","author":"Gibbons","year":"2017","journal-title":"Curr Diab Rep"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:19:58Z","timestamp":1761592798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861925000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0733861925000258"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2025.05.006","relation":{},"ISSN":["0733-8619"],"issn-type":[{"type":"print","value":"0733-8619"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic Neuropathy Part 1","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2025.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}